Phase I Trial of the Safety, Toxicity, and Acceptability of the Microbicide UC-781 When Topically Applied by HIV-Uninfected Women and Men in Botswana
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 15 Aug 2012
At a glance
- Drugs UC 781 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 15 Aug 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
- 05 Jun 2009 New trial record.